Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
An advocacy group that includes the main pharmaceutical lobbying organization, PhRMA, as a member is complaining that a commercial Hims & Hers Health (NYSE:HIMS) is slated to run during the Super Bowl ...
Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications. Set to the "This Is America" by Childish Gambino (Donald Glover), the ...
Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...
Telehealth company Hims & Hers is running its first Super Bowl ad and it appears to be poised to become one of the most talked about ads in recent memory. The 60 second spot is provocative and ...
Telehealth company Hims & Hers Health (HIMS) recently stirred up controversy with its ad promoting its compounded weight-loss ...
Two new customer-led programs from Hims & Hers, the Hims & Hers Health Collective and the Hims & Hers Community Member Council, are born from the company's commitment to serving its customers in ...
Here’s the lowdown on how it works and what it costs. Share on Pinterest Hers, a part of the Hims & Hers Health platform, grew popular for its hair loss program and products. It’s also well ...
Hims & Hers sells compounded semaglutide, a version of the active ingredient in Novo Nordisk’s Wegovy and Ozempic drugs. (Hims & Hers Health) Telehealth provider Hims & Hers Health is defending ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results